Pharmagreen Biotech Inc. Announces that Registration Statement on Form S-1 has been Declared Effective – Pharmagreen is a Cannabis Company that is a producer of highest quality CBD Hemp Plantlets

Pharmagreen Biotech, Inc., announced that the Securities and Exchange Commission (“SEC”) has declared effective the Company’s registration on Form S-1 (file 333-230413) relating to the sale from treasury of up to 20,000,000 shares of the Company’s Class A common stock at an issue price of $2 per share, and the resale of 4,051,725 common stock  that have been issued to the Selling Stockholders named in this registration statement.

Pharmagreen will not receive any proceeds from the re-sale of the securities by the selling security stockholders.  Pharmagreen will receive the proceeds from the sale of the 20,000,000 shares issued out of treasury.

The registration statement may be accessed through the SEC’s website at www.sec.gov. A copy of the prospectus relating to the offering may be obtained from Pharmagreen by writing Pharmagreen Biotech Inc., 2987 Blackbear Court, Coquitlam, BC, Canada, V3E 3A2 or emailing pw@pharmagreen.ca.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.